Kenneth L Gayron Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kenneth L Gayron.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kenneth L Gayron. Kenneth L Gayron is a Chief Financial Officer & EVP in AVID TECHNOLOGY, INC. ($AVID) and a EVP & Chief Financial Officer in AVID TECHNOLOGY, INC. ($AVID) and a Chief Financial Officer in NUMEREX CORP /PA/ ($NMRX) and a INTERIM CEO AND CFO in NUMEREX CORP /PA/ ($NMRX) and a Director in EYEGATE PHARMACEUTICALS INC ($EYEG).
Address: 3330 CUMBERLAND BLVD SE SUITE 700 ATLANTA 30339 GA
Companies in which Kenneth L Gayron is an Insider
AVID TECHNOLOGY, INC.
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of Kenneth L Gayron: Chief Financial Officer & EVP, EVP & Chief Financial Officer
Holdings: 233,438 shares
Current Value: $1,318,925
Latest Transaction: Mar 16 2021
$AVID Market Capitalization: $223.44M
$AVID Previous Close: $5.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EYEGATE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth L Gayron: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 21 2021
$EYEG Market Capitalization: $15.24M
$EYEG Previous Close: $1.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NUMEREX CORP /PA/
Industry: COMMUNICATIONS EQUIPMENT, NEC [3669]
Position of Kenneth L Gayron: INTERIM CEO AND CFO, Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 11 2017
$NMRX Market Capitalization: $108.10M
$NMRX Previous Close: $5.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Kenneth L Gayron
Sentiment: All, AVID, EYEG, NMRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2021 | EYEG | EYEGATE PHARMACEUT ... | Gayron Kenneth L | Director | Option Exercise | A | 4.40 | 4,000 | 17,600 | 4,000 | |
| Mar 16 2021 | AVID | AVID TECHNOLOGY, I ... | Gayron Kenneth L | Chief Financial Off ... | Option Exercise | A | 0.00 | 24,137 | 0 | 24,137 | |
| Mar 16 2021 | AVID | AVID TECHNOLOGY, I ... | Gayron Kenneth L | Chief Financial Off ... | Option Exercise | M | 21.75 | 25,414 | 552,755 | 50,829 | |
| Mar 16 2021 | AVID | AVID TECHNOLOGY, I ... | Gayron Kenneth L | Chief Financial Off ... | Option Exercise | M | 21.75 | 8,024 | 174,522 | 8,026 | |
| Mar 16 2021 | AVID | AVID TECHNOLOGY, I ... | Gayron Kenneth L | Chief Financial Off ... | Option Exercise | M | 21.75 | 25,416 | 552,798 | 25,414 | |
| Mar 16 2021 | AVID | AVID TECHNOLOGY, I ... | Gayron Kenneth L | Chief Financial Off ... | Grant | A | 0.00 | 24,137 | 0 | 294,570 | 270.4 K to 294.6 K (+8.93 %) |
| Mar 16 2021 | AVID | AVID TECHNOLOGY, I ... | Gayron Kenneth L | Chief Financial Off ... | Payment of Exercise | F | 21.75 | 16,898 | 367,532 | 270,433 | 287.3 K to 270.4 K (-5.88 %) |